COX inhibitors and breast cancer
File(s)COX inhibitors and breast cancer.pdf (159.16 KB)
Published version
Author(s)
Mazhar, D
Ang, R
Waxman, J
Type
Journal Article
Date Issued
2006-02-13
ISSN
0007-0920
Publisher
NATURE PUBLISHING GROUP
Start Page
346
End Page
350
Journal / Book Title
BRITISH JOURNAL OF CANCER
Volume
94
Issue
3
Copyright Statement
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License.
To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000235183800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Oncology
ONCOLOGY
cyclo-oxygenase (COX)
prostaglandin
breast cancer
NSAIDS
selective COX-2 inhibitor
NONSTEROIDAL ANTIINFLAMMATORY DRUGS
ELEVATED CYCLOOXYGENASE-2 EXPRESSION
GASTROINTESTINAL TOXICITY
MAMMARY TUMORIGENESIS
RHEUMATOID-ARTHRITIS
GENE-EXPRESSION
TRANSGENIC MICE
CELECOXIB
RISK
CARCINOGENESIS
Breast Neoplasms
Clinical Trials as Topic
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Female
Humans
Incidence
Treatment Outcome
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status
Published